Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 12 | 2019 | 1079 | 1.600 |
Why?
|
Exercise | 13 | 2019 | 567 | 1.380 |
Why?
|
Caloric Restriction | 4 | 2019 | 92 | 1.200 |
Why?
|
Aging | 6 | 2017 | 857 | 1.030 |
Why?
|
Aged | 32 | 2020 | 9256 | 0.990 |
Why?
|
Pericardium | 2 | 2011 | 53 | 0.810 |
Why?
|
Adipose Tissue | 4 | 2011 | 337 | 0.800 |
Why?
|
Exercise Therapy | 5 | 2019 | 195 | 0.790 |
Why?
|
Resistance Training | 3 | 2016 | 64 | 0.790 |
Why?
|
Dietary Proteins | 1 | 2020 | 50 | 0.770 |
Why?
|
Inflammation Mediators | 2 | 2012 | 101 | 0.740 |
Why?
|
Abdominal Fat | 3 | 2018 | 46 | 0.680 |
Why?
|
Body Composition | 6 | 2019 | 365 | 0.680 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2018 | 2 | 0.660 |
Why?
|
Scavenger Receptors, Class E | 2 | 2008 | 2 | 0.660 |
Why?
|
Life Style | 3 | 2018 | 372 | 0.660 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 35 | 0.650 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 44 | 0.650 |
Why?
|
Female | 31 | 2020 | 17679 | 0.640 |
Why?
|
Exosomes | 1 | 2018 | 37 | 0.630 |
Why?
|
Postmenopause | 2 | 2011 | 398 | 0.620 |
Why?
|
Inflammation | 3 | 2010 | 501 | 0.620 |
Why?
|
Adiposity | 4 | 2016 | 208 | 0.600 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2018 | 109 | 0.600 |
Why?
|
Male | 29 | 2020 | 16967 | 0.600 |
Why?
|
Geriatrics | 1 | 2018 | 93 | 0.590 |
Why?
|
Humans | 36 | 2020 | 28304 | 0.590 |
Why?
|
Neurons | 1 | 2018 | 191 | 0.570 |
Why?
|
Vascular Diseases | 1 | 2015 | 60 | 0.520 |
Why?
|
Alzheimer Disease | 1 | 2018 | 291 | 0.520 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2011 | 1236 | 0.520 |
Why?
|
Hypertension | 5 | 2017 | 978 | 0.470 |
Why?
|
Electrocardiography | 1 | 2018 | 568 | 0.470 |
Why?
|
Middle Aged | 17 | 2019 | 10678 | 0.460 |
Why?
|
Coronary Circulation | 2 | 2016 | 30 | 0.450 |
Why?
|
Physical Fitness | 3 | 2010 | 114 | 0.430 |
Why?
|
Lipoprotein Lipase | 1 | 2011 | 14 | 0.420 |
Why?
|
Atherosclerosis | 3 | 2015 | 725 | 0.420 |
Why?
|
Brain | 1 | 2018 | 809 | 0.410 |
Why?
|
Myocardium | 2 | 2016 | 197 | 0.410 |
Why?
|
Lipoproteins, VLDL | 1 | 2011 | 27 | 0.410 |
Why?
|
Lipase | 1 | 2011 | 29 | 0.410 |
Why?
|
Aged, 80 and over | 10 | 2017 | 3562 | 0.400 |
Why?
|
C-Reactive Protein | 4 | 2017 | 236 | 0.400 |
Why?
|
Body Mass Index | 6 | 2019 | 890 | 0.380 |
Why?
|
Exercise Tolerance | 4 | 2019 | 110 | 0.380 |
Why?
|
Blood Pressure | 3 | 2015 | 861 | 0.380 |
Why?
|
Ginkgo biloba | 1 | 2010 | 19 | 0.370 |
Why?
|
Nitric Oxide | 2 | 2009 | 109 | 0.370 |
Why?
|
Nitrites | 1 | 2009 | 20 | 0.370 |
Why?
|
Nitrates | 1 | 2009 | 25 | 0.360 |
Why?
|
Plant Extracts | 1 | 2010 | 59 | 0.360 |
Why?
|
Lipoproteins, HDL | 1 | 2011 | 269 | 0.340 |
Why?
|
Lipoproteins, LDL | 1 | 2009 | 77 | 0.340 |
Why?
|
Aorta | 1 | 2009 | 105 | 0.340 |
Why?
|
Comorbidity | 1 | 2009 | 531 | 0.300 |
Why?
|
Logistic Models | 3 | 2018 | 727 | 0.290 |
Why?
|
Heart Failure | 3 | 2018 | 574 | 0.280 |
Why?
|
Interleukin-6 | 3 | 2012 | 224 | 0.260 |
Why?
|
Exercise Test | 4 | 2019 | 192 | 0.250 |
Why?
|
Sex Factors | 2 | 2017 | 619 | 0.250 |
Why?
|
Age Factors | 3 | 2018 | 1058 | 0.210 |
Why?
|
Gait | 3 | 2017 | 100 | 0.200 |
Why?
|
Oxygen Consumption | 4 | 2019 | 138 | 0.200 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 1059 | 0.200 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 211 | 0.190 |
Why?
|
North Carolina | 3 | 2015 | 1412 | 0.190 |
Why?
|
Hand Strength | 2 | 2012 | 82 | 0.190 |
Why?
|
Weight Loss | 2 | 2015 | 411 | 0.190 |
Why?
|
Proteins | 1 | 2020 | 142 | 0.180 |
Why?
|
Chronic Disease | 3 | 2010 | 359 | 0.180 |
Why?
|
Intra-Abdominal Fat | 3 | 2018 | 68 | 0.170 |
Why?
|
Multivariate Analysis | 2 | 2011 | 631 | 0.170 |
Why?
|
Risk Factors | 7 | 2017 | 3520 | 0.170 |
Why?
|
Mobility Limitation | 3 | 2014 | 180 | 0.170 |
Why?
|
Sepharose | 1 | 2018 | 5 | 0.170 |
Why?
|
Biotinylation | 1 | 2018 | 10 | 0.170 |
Why?
|
Body Fat Distribution | 1 | 2018 | 36 | 0.170 |
Why?
|
Treatment Outcome | 3 | 2019 | 2886 | 0.160 |
Why?
|
Research | 1 | 2018 | 67 | 0.160 |
Why?
|
Geriatric Assessment | 4 | 2016 | 328 | 0.160 |
Why?
|
Protein Binding | 1 | 2018 | 182 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 1144 | 0.160 |
Why?
|
Time Factors | 2 | 2015 | 1874 | 0.160 |
Why?
|
Cell Separation | 1 | 2018 | 85 | 0.160 |
Why?
|
Bacterial Proteins | 1 | 2018 | 71 | 0.160 |
Why?
|
Disability Evaluation | 2 | 2019 | 202 | 0.160 |
Why?
|
Avitaminosis | 1 | 2017 | 2 | 0.150 |
Why?
|
Vitamin K 1 | 1 | 2017 | 11 | 0.150 |
Why?
|
Lysine | 1 | 2017 | 23 | 0.150 |
Why?
|
Heart | 1 | 2018 | 175 | 0.150 |
Why?
|
Gene Expression | 1 | 2018 | 324 | 0.150 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2016 | 24 | 0.140 |
Why?
|
Dobutamine | 1 | 2016 | 43 | 0.140 |
Why?
|
Stroke Volume | 1 | 2018 | 278 | 0.140 |
Why?
|
Elasticity | 1 | 2015 | 33 | 0.140 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 37 | 0.130 |
Why?
|
African Continental Ancestry Group | 1 | 2017 | 376 | 0.130 |
Why?
|
Continental Population Groups | 1 | 2017 | 229 | 0.130 |
Why?
|
Waist Circumference | 1 | 2015 | 90 | 0.130 |
Why?
|
Heart Ventricles | 1 | 2016 | 115 | 0.130 |
Why?
|
Forecasting | 1 | 2015 | 130 | 0.130 |
Why?
|
Heart Rate | 1 | 2017 | 325 | 0.130 |
Why?
|
MicroRNAs | 1 | 2017 | 170 | 0.130 |
Why?
|
European Continental Ancestry Group | 2 | 2017 | 1203 | 0.130 |
Why?
|
Single-Blind Method | 2 | 2012 | 151 | 0.130 |
Why?
|
Peripheral Vascular Diseases | 1 | 2014 | 35 | 0.120 |
Why?
|
Forced Expiratory Volume | 1 | 2014 | 112 | 0.120 |
Why?
|
Pilot Projects | 1 | 2015 | 437 | 0.120 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 498 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 486 | 0.120 |
Why?
|
Triglycerides | 2 | 2011 | 220 | 0.120 |
Why?
|
Activities of Daily Living | 2 | 2014 | 216 | 0.110 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2014 | 189 | 0.110 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 9 | 0.110 |
Why?
|
Gene Frequency | 2 | 2014 | 272 | 0.110 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 71 | 0.110 |
Why?
|
Perfusion | 1 | 2011 | 64 | 0.100 |
Why?
|
DNA Primers | 1 | 2011 | 89 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2018 | 886 | 0.100 |
Why?
|
Linear Models | 2 | 2010 | 421 | 0.100 |
Why?
|
Base Sequence | 1 | 2011 | 241 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2011 | 171 | 0.100 |
Why?
|
Hemodynamics | 1 | 2011 | 158 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2011 | 56 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 73 | 0.100 |
Why?
|
Genotype | 2 | 2014 | 813 | 0.100 |
Why?
|
Prospective Studies | 2 | 2015 | 1932 | 0.100 |
Why?
|
Oxidative Stress | 2 | 2009 | 249 | 0.100 |
Why?
|
Coronary Disease | 1 | 2011 | 205 | 0.090 |
Why?
|
Plethysmography | 1 | 2009 | 13 | 0.090 |
Why?
|
Risk Assessment | 1 | 2015 | 1285 | 0.090 |
Why?
|
Multienzyme Complexes | 1 | 2009 | 8 | 0.090 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2009 | 10 | 0.090 |
Why?
|
Follow-Up Studies | 2 | 2015 | 2027 | 0.090 |
Why?
|
Blood Flow Velocity | 1 | 2009 | 59 | 0.090 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 130 | 0.090 |
Why?
|
Probability | 1 | 2009 | 150 | 0.090 |
Why?
|
Double-Blind Method | 1 | 2010 | 480 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 1556 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2010 | 171 | 0.080 |
Why?
|
Cohort Studies | 2 | 2011 | 1673 | 0.080 |
Why?
|
Exons | 1 | 2008 | 54 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 196 | 0.080 |
Why?
|
Thinness | 1 | 2008 | 31 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 203 | 0.080 |
Why?
|
Genetic Testing | 1 | 2008 | 93 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 521 | 0.080 |
Why?
|
Lipids | 1 | 2009 | 215 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 118 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 1345 | 0.080 |
Why?
|
Incidence | 1 | 2010 | 1087 | 0.070 |
Why?
|
Kidney | 1 | 2010 | 495 | 0.070 |
Why?
|
Body Weight | 1 | 2008 | 289 | 0.070 |
Why?
|
Overweight | 1 | 2008 | 254 | 0.070 |
Why?
|
Retrospective Studies | 2 | 2016 | 2930 | 0.070 |
Why?
|
Subcutaneous Fat, Abdominal | 2 | 2018 | 14 | 0.070 |
Why?
|
Adult | 2 | 2011 | 8243 | 0.050 |
Why?
|
Antihypertensive Agents | 2 | 2017 | 378 | 0.050 |
Why?
|
Health Education | 2 | 2014 | 119 | 0.050 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 111 | 0.040 |
Why?
|
Executive Function | 1 | 2019 | 51 | 0.040 |
Why?
|
Fatigue | 1 | 2019 | 68 | 0.040 |
Why?
|
Thigh | 1 | 2018 | 39 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 370 | 0.040 |
Why?
|
Muscle Strength | 1 | 2018 | 123 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 46 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 40 | 0.040 |
Why?
|
Blood Glucose | 1 | 2019 | 485 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 85 | 0.040 |
Why?
|
Echocardiography, Stress | 1 | 2016 | 22 | 0.040 |
Why?
|
Coronary Stenosis | 1 | 2016 | 29 | 0.030 |
Why?
|
Calcinosis | 1 | 2017 | 158 | 0.030 |
Why?
|
Microcirculation | 1 | 2016 | 61 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2016 | 43 | 0.030 |
Why?
|
Cognition | 1 | 2019 | 512 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 706 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 149 | 0.030 |
Why?
|
Spirometry | 1 | 2014 | 32 | 0.030 |
Why?
|
Brachial Artery | 1 | 2014 | 65 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 229 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 418 | 0.030 |
Why?
|
Stroke | 1 | 2017 | 443 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 59 | 0.030 |
Why?
|
Dinoprost | 1 | 2009 | 9 | 0.020 |
Why?
|
Nitrogen Oxides | 1 | 2009 | 5 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 27 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2009 | 39 | 0.020 |
Why?
|
Antioxidants | 1 | 2009 | 117 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2009 | 390 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 165 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 441 | 0.020 |
Why?
|
United States | 1 | 2015 | 3588 | 0.020 |
Why?
|
Health Status | 1 | 2008 | 360 | 0.020 |
Why?
|
Animals | 1 | 2010 | 6402 | 0.010 |
Why?
|